LPL Financial
ABCL icon

LPL Financial’s AbCellera Biologics ABCL Stock Holding History

LPL Financial’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$425K Buy
121,813
+73,109
+150% +$263K ﹤0.01% 4909
2025
Q4 		$167K Buy
48,704
+12,954
+36% +$57.8K ﹤0.01% 5498
2025
Q3 		$180K Buy
35,750
+17,526
+96% +$77.2K ﹤0.01% 5385
2025
Q2 		$62.5K Buy
+18,224
New +$45.4K ﹤0.01% 5338
2024
Q4 		– Sell
-13,313
Closed -$34.6K – 5275
2024
Q3 		$34.6K Sell
13,313
-5,750
-30% -$15.9K ﹤0.01% 5037
2024
Q2 		$56.4K Sell
19,063
-46,680
-71% -$177K ﹤0.01% 4826
2024
Q1 		$298K Buy
+65,743
New +$335K ﹤0.01% 4205

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return